Opening book details…
About this nonfiction
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial by Özgüroğlu, Mustafa (author);Kilickap, Saadettin (author);Sezer, Ahmet (author);Gümüş, Mahmut (author);Bondarenko, Igor (author);Gogishvili, Miranda (author);Nechaeva, Marina (author);Schenker, Michael (author);Cicin, Irfan (author);Ho, Gwo Fuang (author);Kulyaba, Yaroslav (author);Zyuhal, Kasimova (author);Scheusan, Roxana-Ioana (author);Garassino, Marina Chiara (author);He, Xuanyao (author);Kaul, Manika (author);Okoye, Emmanuel (author);Li, Yuntong (author);Li, Siyu (author);Pouliot, Jean-Francois (author);Seebach, Frank (author);Lowy, Israel (author);Gullo, Giuseppe (author);Rietschel, Petra (author) is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Özgüroğlu, Mustafa (author);Kilickap, Saadettin (author);Sezer, Ahmet (author);Gümüş, Mahmut (author);Bondarenko, Igor (author);Gogishvili, Miranda (author);Nechaeva, Marina (author);Schenker, Michael (author);Cicin, Irfan (author);Ho, Gwo Fuang (author);Kulyaba, Yaroslav (author);Zyuhal, Kasimova (author);Scheusan, Roxana-Ioana (author);Garassino, Marina Chiara (author);He, Xuanyao (author);Kaul, Manika (author);Okoye, Emmanuel (author);Li, Yuntong (author);Li, Siyu (author);Pouliot, Jean-Francois (author);Seebach, Frank (author);Lowy, Israel (author);Gullo, Giuseppe (author);Rietschel, Petra (author)
- Publisher
- Elsevier BV
- Published
- 2023
- Language
- EN
- Category
- nonfiction
More by Özgüroğlu, Mustafa (author);Kilickap, Saadettin (author);Sezer, Ahmet (author);Gümüş, Mahmut (author);Bondarenko, Igor (author);Gogishvili, Miranda (author);Nechaeva, Marina (author);Schenker, Michael (author);Cicin, Irfan (author);Ho, Gwo Fuang (author);Kulyaba, Yaroslav (author);Zyuhal, Kasimova (author);Scheusan, Roxana-Ioana (author);Garassino, Marina Chiara (author);He, Xuanyao (author);Kaul, Manika (author);Okoye, Emmanuel (author);Li, Yuntong (author);Li, Siyu (author);Pouliot, Jean-Francois (author);Seebach, Frank (author);Lowy, Israel (author);Gullo, Giuseppe (author);Rietschel, Petra (author)
Similar books
- Cemiplimab Monotherapy for First-line Treatment of Advanced Non-small-cell Lung Cancer with PD-L1 of at Least 50%: a Multicentre, Open-label, Global, Phase 3, Randomised, Controlled Trial — Sezer, Ahmet; Kilickap, Saadettin; Gümüş, Mahmut; Bondarenko, Igor; Özgüroğlu, Mustafa; Gogishvili, Miranda; Turk, Haci M; Cicin, Irfan; Bentsion, Dmitry; Gladkov, Oleg; Clingan, Philip; Sriuranpong, Virote; Rizvi, Naiyer; Gao, Bo; Li, Siyu; Lee, Sue; McGuire, Kristina; Chen, Chieh-I; Makharadze, Tamta; Paydas, Semra; Nechaeva, Marina; Seebach, Frank; Weinreich, David M; Yancopoulos, George D; Gullo, Giuseppe; Lowy, Israel; Rietschel, Petra (2021)
- Ivonescimab Versus Pembrolizumab for PD-L1-positive Non-small Cell Lung Cancer (HARMONi-2): a Randomised, Double-blind, Phase 3 Study in China — Xiong, Anwen; Wang, Lei; Chen, Jianhua; Wu, Lin; Liu, Baogang; Yao, Jun; Zhong, Hua; Li, Jie; Cheng, Ying; Sun, Yulan; Ge, Hui; Yao, Jifang; Shi, Qin; Zhou, Ming; Chen, Bolin; Han, Zhengxiang; Wang, Jinliang; Bu, Qing; Zhao, Yanqiu; Chen, Junqiang; Nie, Ligong; Li, Gaofeng; Li, Xingya; Yu, Xinmin; Ji, Yinghua; Sun, Daqiang; Ai, Xiaohong; Chu, Qian; Lin, Yu; Hao, Jiqing; Huang, Dingzhi; Zhou, Chengzhi; Shan, Jinlu; Yang, Hongzhong; Liu, Xuewen; Wang, Jing; Shang, Yanhong; Mei, Xiaodong; Yang, Jie; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Zhou, Caicun (2025)
- Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected Stage IB–IIIA Non-small-cell Lung Cancer (IMpower010): a Randomised, Multicentre, Open-label, Phase 3 Trial — Felip, Enriqueta; Altorki, Nasser; Zhou, Caicun; Csőszi, Tibor; Vynnychenko, Ihor; Goloborodko, Oleksandr; Luft, Alexander; Akopov, Andrey; Martinez-Marti, Alex; Kenmotsu, Hirotsugu; Chen, Yuh-Min; Chella, Antonio; Sugawara, Shunichi; Voong, David; Wu, Fan; Yi, Jing; Deng, Yu; McCleland, Mark; Bennett, Elizabeth; Gitlitz, Barbara; Wakelee, Heather (2021)
- Home-based Transcranial Direct Current Stimulation for Major Depressive Disorder: 6-Month Follow-up from Randomised Sham-controlled Trial and Open-label Treatment Phases — Woodham, Rachel D.; Selvaraj, Sudhakar; Lajmi, Nahed; Hobday, Harriet; Sheehan, Gabrielle; Ghazi-Noori, Ali-Reza; Lagerberg, Peter J.; Machado-Vieira, Rodrigo; Soares, Jair C.; Young, Allan H.; Fu, Cynthia H.Y. (2025)
- Tiragolumab Plus Atezolizumab Versus Placebo Plus Atezolizumab as a First-line Treatment for PD-L1-selected Non-small-cell Lung Cancer (CITYSCAPE): Primary and Follow-up Analyses of a Randomised, Double-blind, Phase 2 Study — Cho, Byoung Chul; Abreu, Delvys Rodriguez; Hussein, Maen; Cobo, Manuel; Patel, Anjan J; Secen, Nevena; Lee, Ki Hyeong; Massuti, Bartomeu; Hiret, Sandrine; Yang, James Chih Hsin; Barlesi, Fabrice; Lee, Dae Ho; Ares, Luis Paz; Hsieh, Robert W; Patil, Namrata S; Twomey, Patrick; Yang, Xiaoying; Meng, Raymond; Johnson, Melissa L (2022)
- Doublet Chemotherapy, Triplet Chemotherapy, or Doublet Chemotherapy Combined with Radiotherapy as Neoadjuvant Treatment for Locally Advanced Oesophageal Cancer (JCOG1109 NExT): a Randomised, Controlled, Open-label, Phase 3 Trial — Kato, Ken; Machida, Ryunosuke; Ito, Yoshinori; Daiko, Hiroyuki; Ozawa, Soji; Ogata, Takashi; Hara, Hiroki; Kojima, Takashi; Abe, Tetsuya; Bamba, Takeo; Watanabe, Masaya; Kawakubo, Hirofumi; Shibuya, Yuichi; Tsubosa, Yasuhiro; Takegawa, Naoki; Kajiwara, Takeshi; Baba, Hideo; Ueno, Masaki; Takeuchi, Hiroya; Nakamura, Kenichi; Kitagawa, Yuko; Komatsu, Yoshito; Akiyama, Yuji; Takahashi, Masanobu; Amagai, Kenji; Matsushita, Naoyuki; Hara, Hiroki; Sato, Hiroshi; Kojima, Takashi; Minashi, Keiko; Matsubara, Hisahiro; Kikuchi, Yuji; Kato, Ken; Narumiya, Kosuke; Kitagawa, Yuko; Kubota, Yutaro; Watanabe, Masayuki; Ueno, Masaki; Ozawa, Soji; Ogata, Takashi; Bamba, Takeo; Ichikawa, Hiroshi; Watanabe, Masaya; Tsubosa, Yasuhiro; Takeuchi, Hiroya; Abe, Tetsuya; Koike, Masahiko; Tsunoda, Shigeru; Doki, Yuichiro; Miyata, Hiroshi; Hirano, Motohiro; Ikeda, Hiroko; Goto, Masahiro; Minami, Hironobu; Masuzawa, Toru; Tsuda, Masahiro; Okada, Morihito; Mukai, Hidenori; Kajiwara, Takeshi; Shibuya, Yuichi; Morita, Masaru; Baba, Eishi; Baba, Hideo; Inomata, Masafumi; Sasaki, Ken (2024)